Biosketch / Results /

Mikhail Kogan

Clinical Assistant Professor, Department of Anesthesiology, Perioperative Care, and Pain Medicine

Contact Info

718/544-1171


Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Motzer, Robert J; Nosov, Dmitry; Eisen, Timothy; Bondarenko, Igor; Lesovoy, Vladimir; Lipatov, Oleg; Tomczak, Piotr; Lyulko, Oleksiy; Alyasova, Anna; Harza, Mihai; Kogan, Mikhail; Alekseev, Boris Y; Sternberg, Cora N; Szczylik, Cezary; Cella, David; Ivanescu, Cristina; Krivoshik, Andrew; Strahs, Andrew; Esteves, Brooke; Berkenblit, Anna; Hutson, Thomas E. Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial. Journal of clinical oncology. 2013 Sep 9;31(30):3791-3799 (549032)

Mind-body medicine therapies for a range of depression severity: a systematic review
D'Silva, Sahana; Poscablo, Cristina; Habousha, Racheline; Kogan, Mikhail; Kligler, Benjamin. Mind-body medicine therapies for a range of depression severity: a systematic review. Psychosomatics. 2012 Sep -1;53(5):407-423 (549042)

Mirror box therapy: seeing is believing
Lamont, Kelly; Chin, May; Kogan, Mikhail. Mirror box therapy: seeing is believing. Explore : the journal of science & healing. 2011 Nov -1;7(6):369-372 (549052)